Company intelligence / Profile preview

AlivaMab Discovery Services

San Diego, California, United Statesalivamab.com ↗

Ownership: Private
Development stage: Commercial

Overview

Provides rapid generation of molecularly diverse panels of drug-quality human antibodies with deep functional and kinetic characterization. Supports downstream engineering for advanced modalities. No clinical results reported as it is a service provider.

Modalities: Monoclonal antibodyBispecific monoclonal antibodyCAR-T cell therapy components/engineering supportMultispecific antibodies
Industry: Contract Research Organization

Partnerships

IGM BiosciencesAbbVieAstraZenecaBristol Myers SquibbNovartisPfizerRoche/GenentechAblexis

Beyond the preview

Go deeper on AlivaMab Discovery Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AlivaMab Discovery Services.

Explore the full profile